MITK vs REGN · P/E 34, rev $172.1M vs P/E 14, rev $14.34B
Mitek Systems Inc (MITK) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Mitek Systems Inc (MITK) is a software - application company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MITK revenue for 2024-09-30 was $172.1M. Net income was $3.3M. Revenue was up 357.0% from 2023-09-30 to 2024-09-30. MITK currently screens at market cap $451.1M and trailing P/E 34.1.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MITK currently screens at market cap $451.1M and trailing P/E 34.1. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MITK and REGN stock pages for the full models.
Not investment advice.